|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.52 USD | -5.90% |
|
-4.88% | +10.16% |
| 05-07 | Prothena Corporation plc Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-27 | Prothena Says Novo Nordisk Gets FDA Fast Track Designation for Coramitug in ATTR-CM | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 11.51 | 11.51 | 11.07 |
| Spread/Res. | -8.60% | -8.60% | -4.97% |
| Spread/Supp. | +2.04% | +10.50% | +35.57% |
| Support | 10.31 | 9.52 | 7.76 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- PRTA Stock
- Charts Prothena Corporation plc
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition